BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23873492)

  • 1. Riboflavin/UVA photochemical therapy for severe infectious keratitis.
    Skaat A; Zadok D; Goldich Y; Varssano D; Berger Y; Ezra-Nimni O; Avni I; Barequet IS
    Eur J Ophthalmol; 2014; 24(1):21-8. PubMed ID: 23873492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial keratitis after corneal collagen crosslinking.
    Pérez-Santonja JJ; Artola A; Javaloy J; Alió JL; Abad JL
    J Cataract Refract Surg; 2009 Jun; 35(6):1138-40. PubMed ID: 19465303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of infectious keratitis with riboflavin and ultraviolet-A irradiation.
    Chan E; Snibson GR; Sullivan L
    J Cataract Refract Surg; 2014 Nov; 40(11):1919-25. PubMed ID: 25262564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study.
    Makdoumi K; Mortensen J; Sorkhabi O; Malmvall BE; Crafoord S
    Graefes Arch Clin Exp Ophthalmol; 2012 Jan; 250(1):95-102. PubMed ID: 21874347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas keratitis after collagen crosslinking for keratoconus: case report and review of literature.
    Sharma N; Maharana P; Singh G; Titiyal JS
    J Cataract Refract Surg; 2010 Mar; 36(3):517-20. PubMed ID: 20202556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymicrobial keratitis after a collagen cross-linking procedure with postoperative use of a contact lens: a case report.
    Zamora KV; Males JJ
    Cornea; 2009 May; 28(4):474-6. PubMed ID: 19411973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts.
    Iseli HP; Thiel MA; Hafezi F; Kampmeier J; Seiler T
    Cornea; 2008 Jun; 27(5):590-4. PubMed ID: 18520510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corneal collagen cross-linking for infectious keratitis: an update of clinical studies.
    Chan TC; Lau TW; Lee JW; Wong IY; Jhanji V; Wong RL
    Acta Ophthalmol; 2015 Dec; 93(8):689-96. PubMed ID: 25990098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases.
    Khan YA; Kashiwabuchi RT; Martins SA; Castro-Combs JM; Kalyani S; Stanley P; Flikier D; Behrens A
    Ophthalmology; 2011 Feb; 118(2):324-31. PubMed ID: 20884060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A.
    Pollhammer M; Cursiefen C
    J Cataract Refract Surg; 2009 Mar; 35(3):588-9. PubMed ID: 19251154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli keratitis treated with ultraviolet A/riboflavin corneal cross-linking: a case report.
    Micelli Ferrari T; Leozappa M; Lorusso M; Epifani E; Micelli Ferrari L
    Eur J Ophthalmol; 2009; 19(2):295-7. PubMed ID: 19253251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial efficacy of accelerated photoactivated chromophore for keratitis-corneal collagen cross-linking (PACK-CXL).
    Richoz O; Kling S; Hoogewoud F; Hammer A; Tabibian D; Francois P; Schrenzel J; Hafezi F
    J Refract Surg; 2014 Dec; 30(12):850-4. PubMed ID: 25437485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PACK-CXL: defining CXL for infectious keratitis.
    Hafezi F; Randleman JB
    J Refract Surg; 2014 Jul; 30(7):438-9. PubMed ID: 24983827
    [No Abstract]   [Full Text] [Related]  

  • 14. Does PACK-CXL Change the Prognosis of Resistant Infectious Keratitis?
    Zloto O; Barequet IS; Weissman A; Ezra Nimni O; Berger Y; Avni-Zauberman N
    J Refract Surg; 2018 Aug; 34(8):559-563. PubMed ID: 30089187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photoactivated Chromophore for Moderate to Severe Infectious Keratitis as an Adjunct Therapy: A Randomized Controlled Trial.
    Kasetsuwan N; Reinprayoon U; Satitpitakul V
    Am J Ophthalmol; 2016 May; 165():94-9. PubMed ID: 26949133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology.
    Price MO; Tenkman LR; Schrier A; Fairchild KM; Trokel SL; Price FW
    J Refract Surg; 2012 Oct; 28(10):706-13. PubMed ID: 23062001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated Corneal Cross-Linking With Photoactivated Chromophore for Moderate Therapy-Resistant Infectious Keratitis.
    Knyazer B; Krakauer Y; Baumfeld Y; Lifshitz T; Kling S; Hafezi F
    Cornea; 2018 Apr; 37(4):528-531. PubMed ID: 29300262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious keratitis treated with corneal crosslinking.
    Makdoumi K; Mortensen J; Crafoord S
    Cornea; 2010 Dec; 29(12):1353-8. PubMed ID: 21102196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen Cross-linking With Photoactivated Riboflavin (PACK-CXL) for Bacterial Keratitis After Small Incision Lenticule Extraction (SMILE).
    Chan TC; Chow VW; Jhanji V
    J Refract Surg; 2017 Apr; 33(4):278-280. PubMed ID: 28407169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoactivated chromophore corneal cross-linking (PACK-CXL) for treatment of severe keratitis.
    Idrus EA; Utti EM; Mattila JS; Krootila K
    Acta Ophthalmol; 2019 Nov; 97(7):721-726. PubMed ID: 30593737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.